FDA Inspection 1224007 — Bergen Community Regional Blood Center
The FDA completed an inspection of Bergen Community Regional Blood Center on Nov 21, 2023 in Lincoln Park, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 21, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lincoln Park, NJ (United States)